483
GLPGCP Development (Asia) Pte. Ltd.FDA 483 - GLPGCP Development (Asia) Pte. Ltd. - June 22, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of GPC Medical Ltd. in New Delhi, India, revealed significant deficiencies in their quality system for device manufacturing. The firm was cited for inadequate procedures concerning labeling activities, process validation, and the acceptance and control of both in-process and finished devices. These observations highlight a need for comprehensive improvements in their operational controls.
Open in Dashboard
ID · 8bad919d-c1b6-4fee-b805-fadc9ef0faa4